Feasıbılıty and safety of vıdeo-assısted thoracıc surgery after neoadjuvant chemoımmunotherapy ın non-small cell lung cancer: A sıngle-centre experıence
View Full Paper
Ask AI
Bookmark
Share
Key Points
VATS demonstrated significant feasibility and safety in NSCLC patients following neoadjuvant chemoimmunotherapy.
A total of 58.8% of procedures utilized VATS with no conversions to open surgery, indicating effectiveness.
Intensive care unit stay was significantly shorter in the VATS group compared to open surgery, highlighting benefits.
Post-operative complications occurred in 41.2% of patients, but no 90-day mortality was reported, ensuring safety.
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Observational analysis showed VATS is feasible in NSCLC patients after neoadjuvant chemoimmunotherapy, indicating good short-term outcomes.